I obtained my Bachelor's of Science degree in Biological sciences from Northeastern University in 2018. I am currently a Research Technician II working in the Sorger Lab at Harvard Medical School, and am affilated with the Laboratory of Systems Pharmacology (LSP). Before joining the LSP, I was a research assistant at Repligen,  Northeastern University's Center for Drug Discovery, and Pfizer Cambridge, where I worked to investigate the roles of intracellular receptors in addiction, Alzheimer's disease, and drug sensitivity. My work in the LSP includes dose response profiling of anti-cancer therapeutics across multiple cell lines as part of the LINCS project, as well as using CRISPR-Cas9 technology to develop in-vitro model systems to probe cancer biology.  At the onset of the COVID19 pandemic,  I worked with the Springer Lab at Harvard Medical School to develop a new rapid test for the SARS-CoV-2 virus, and my current work involves using CRISPRa and CRISPRi techniques to characterize the function of transporter proteins and identify potential therapeutic targets for metabolic diseases and cancer.  My future plans are to earn a Master's degree in biology and a certificate in bioinformatics from the Harvard University Extension School and become proficient in programming and data analysis.  I hope to continue producing high quality, reproducible data and develop the experience to take on diverse and complex scientific problems.